Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Kerr

Showing results (261-270 of 302) with videos related to

Pageof 31
Sort By:
European Journal of Heart Failure|August 22, 2024
Clinical characteristics and outcomes of patients aged 80 years and over with heart failure: Need for better treatmentMingming Yang, Toru Kondo, Inder S Anand, et al.
Circulation|July 13, 2023
STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label TrialFrans Van de Werf, Arsen D Ristić, Oleg V Averkov, et al.
Journal of the American Heart Association|June 11, 2025
Race and Ethnicity in Heart Failure Trials: Time to Update Recommended Categories for Global RelevanceMingming Yang, Toru Kondo, Pooja Dewan, et al.
Journal of the American Society of Nephrology : JASN|September 22, 2016
African Ancestry-Specific Alleles and Kidney Disease Risk in Hispanics/LatinosHolly J Kramer, Adrienne M Stilp, Cathy C Laurie, et al.
Cardiovascular Diabetology|July 31, 2025
Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: a prespecified analysis of the DARE-19 randomized trialMohammad Abdel Jawad, Remo H M Furtado, Russell Esterline, et al.
JAMA Cardiology|November 3, 2022
Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER Randomized Clinical TrialFinnian R Mc Causland, Brian L Claggett, Muthiah Vaduganathan, et al.
Journal of the American College of Cardiology|November 9, 2024
Effect of Finerenone on the KCCQ in Patients With HFmrEF/HFpEF: A Prespecified Analysis of FINEARTS-HFMingming Yang, Alasdair D Henderson, Atefeh Talebi, et al.
JAMA|October 27, 2014
Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosisJ Gustav Smith, Kevin Luk, Christina-Alexandra Schulz, et al.
Journal of Dental Research|January 13, 2017
GWAS Identifies New Loci for Painful Temporomandibular Disorder: Hispanic Community Health Study/Study of LatinosA E Sanders, D Jain, T Sofer, et al.
JAMA Cardiology|November 12, 2023
Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical TrialFinnian R Mc Causland, Brian L Claggett, Muthiah Vaduganathan, et al.
Pageof 31

Showing results (261-270 of 302) with videos related to

Sort By:
Pageof 31
European Journal of Heart Failure|August 22, 2024
Clinical characteristics and outcomes of patients aged 80 years and over with heart failure: Need for better treatmentMingming Yang, Toru Kondo, Inder S Anand, et al.
Circulation|July 13, 2023
STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label TrialFrans Van de Werf, Arsen D Ristić, Oleg V Averkov, et al.
Journal of the American Heart Association|June 11, 2025
Race and Ethnicity in Heart Failure Trials: Time to Update Recommended Categories for Global RelevanceMingming Yang, Toru Kondo, Pooja Dewan, et al.
Journal of the American Society of Nephrology : JASN|September 22, 2016
African Ancestry-Specific Alleles and Kidney Disease Risk in Hispanics/LatinosHolly J Kramer, Adrienne M Stilp, Cathy C Laurie, et al.
Cardiovascular Diabetology|July 31, 2025
Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: a prespecified analysis of the DARE-19 randomized trialMohammad Abdel Jawad, Remo H M Furtado, Russell Esterline, et al.
JAMA Cardiology|November 3, 2022
Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER Randomized Clinical TrialFinnian R Mc Causland, Brian L Claggett, Muthiah Vaduganathan, et al.
Journal of the American College of Cardiology|November 9, 2024
Effect of Finerenone on the KCCQ in Patients With HFmrEF/HFpEF: A Prespecified Analysis of FINEARTS-HFMingming Yang, Alasdair D Henderson, Atefeh Talebi, et al.
JAMA|October 27, 2014
Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosisJ Gustav Smith, Kevin Luk, Christina-Alexandra Schulz, et al.
Journal of Dental Research|January 13, 2017
GWAS Identifies New Loci for Painful Temporomandibular Disorder: Hispanic Community Health Study/Study of LatinosA E Sanders, D Jain, T Sofer, et al.
JAMA Cardiology|November 12, 2023
Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical TrialFinnian R Mc Causland, Brian L Claggett, Muthiah Vaduganathan, et al.
Pageof 31